A detailed history of Sage Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sage Capital Management, LLC holds 1,023 shares of LLY stock, worth $765,214. This represents 0.44% of its overall portfolio holdings.

Number of Shares
1,023
Previous 1,023 -0.0%
Holding current value
$765,214
Previous $926 Million 2.04%
% of portfolio
0.44%
Previous 0.49%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $741,542 - $929,947
1,023 New
1,023 $926 Million
Q1 2024

Jul 31, 2024

BUY
$592.2 - $792.28 $37,900 - $50,705
64 Added 6.26%
1,087 $846 Million
Q4 2023

Jul 31, 2024

BUY
$525.19 - $619.13 $33,612 - $39,624
64 Added 6.26%
1,087 $633 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sage Capital Management, LLC Portfolio

Follow Sage Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Management, LLC with notifications on news.